DanCann Pharma's CEO Jeppe Krog Rasmussen in the BioStock studio

DanCann Pharma on the path to commercial breakthrough

DanCann Pharma operates in a growing area of ​​drug development – ​​medical cannabis and therapeutic cannabinoids. The goal is to...

November 7

DanCann Pharma rides the cannabis legalization wave

We are seeing a shift in the political...

November 4
DanCann Pharma's CEO Jeppe Krog Rasmussen presents in BioStock's studio

BioStock Investor Pitch: DanCann Pharma

Danish pharmaceutical company DanCann Pharma's goal is to improve...

November 2
DanCann Pharma

DanCann Pharma towards commercialization with rights issue

For DanCann, the aim is clear – to...

31 October 2022

DanCann Pharma's CEO on the new acquisition

Danish biotechnology company DanCann Pharma has acquired CannGros,...

7 October 2021

DanCann Pharma's CEO on the new milestone

DanCann Pharma has completed its first successful production...

August 17

DanCann's CEO on expectations for the coming months

The Danish biopharma company DanCann Pharma has had a...

August 4

Extended cannabis program in Denmark gives DanCann Pharma a boost

Last week, Danish drug developer DanCann Pharma was able to...

31th of May 2021
Aptahome

DanCann's CEO on the intense news flow

The use of medical cannabis is gaining momentum in...

7th of May 2021

DanCann Pharma starts production of medical cannabis

Danish pharmaceutical company DanCann Pharma's first factory for...

22th April 2021

DanCann's CEO predicts a news-intensive spring

Strengthened by a unique pilot project for medical cannabis...

March 11, 2021

IPO-ready DanCann Pharma develops medical cannabis with NASA technology

Danish biotechnology company DanCann Pharma's goal is to...

2 October 2020

NEWSLETTER

You deserve the best!

Unlock our premium content: Become a subscriber!

Create Account

Tip the editors